Did you mean mechanism of activon?
Displaying drugs 51 - 75 of 622 in total
Tafasitamab
Tafasitamab is a humanized, CD19-directed cytolytic monoclonal antibody intended for the treatment of B-cell malignancies. It is produced using recombinant DNA technology in Chinese hamster ovary cells, and contains an IgG1/2 hybrid Fc-domain which has been modified with 2 amino acid substitutions to enhance its cytotoxicity relative to non-engineered anti-CD19...
Approved
Investigational
Matched Description: … results in the lysis of B-cells (both healthy and malignant). ... Tafasitamab is a humanized, CD19-directed cytolytic monoclonal antibody intended for the treatment of ... [L15292,A191829]
The CD19 surface protein is highly expressed on the surface of B-cells, where it …
Empagliflozin
Empagliflozin is an inhibitor of sodium-glucose co-transporter-2 (SGLT2), the transporters primarily responsible for the reabsorption of glucose in the kidney. It is used clinically as an adjunct to diet and exercise, often in combination with other drug therapies,[L13673,L13679,L11479] for the management of type 2 diabetes mellitus. The first known inhibitor...
Approved
Matched Description: … [L13688]
The first known inhibitor of SGLTs, phlorizin, was isolated from the bark of apple trees ... [A203501] Attempts at overcoming these limitations first saw the development of O-glucoside analogs of ... responsible for the reabsorption of glucose in the kidney. …
Huperzine A
Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss Huperzia serrata. The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders. Recently in clinical trials in China, it has demonstrated neuroprotective effects. It is currently being...
Approved
Experimental
Matched Description: … Huperzine A, is a naturally occurring sesquiterpene alkaloid found in the extracts of the firmoss _Huperzia ... The botanical has been used in China for centuries for the treatment of swelling, fever and blood disorders …
Enoximone
Enoximone is a selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure. Trials were halted in the U.S., but the drug is used in various countries.
Approved
Investigational
Lifileucel
Lifileucel is a tumour-derived autologous T cell immunotherapy composed of a suspension of tumour-derived T cells from the patient which undergo isolation, ex vivo expansion, and activation Lifileucel was granted accelerated approval by the FDA on February 16, 2024, for the treatment of unresectable or metastatic melanoma.
Approved
Investigational
Matched Description: … Lifileucel is a tumour-derived autologous T cell immunotherapy composed of a suspension of tumour-derived ... A263341] Lifileucel was granted accelerated approval by the FDA on February 16, 2024, for the treatment of …
Docusate
Docusate, or dioctyl sulfosuccinate, is a stool softener indicated for the treatment of constipation . Docusate acts by increasing the amount of water the stool absorbs in the gut, making the stool softer and easier to pass . Docusate can be orally or rectally administered. Docusate is on the World...
Approved
Matched Description: … Docusate is on the World Health Organization's List of Essential Medicines[L5915]. ... Docusate, or dioctyl sulfosuccinate, is a stool softener indicated for the treatment of constipation[ ... Docusate acts by increasing the amount of water the stool absorbs in the gut, making the stool softer …
Matched Mixtures name: … Senna S Dual Action ... Senna S Dual Action …
Matched Mixtures name: … Senna S Dual Action ... Senna S Dual Action …
Mephenytoin
Mephenytoin is used for the treatment of refractory partial epilepsy. Mephenytoin is a solid. This compound belongs to the phenylhydantoins. These are heterocyclic aromatic compounds containing an imiazolidinedione moiety substituted by a phenyl group. Mephenytoin is known to target sodium channel protein type 5 subunit alpha. Cytochrome P450 2C19, Cytochrome...
Approved
Investigational
Withdrawn
Matched Description: … Mephenytoin is used for the treatment of refractory partial epilepsy. Mephenytoin is a solid. ... Mephenytoin and oxazolidinedione derivatives are associated with higher incidences of blood dyscrasias …
Indium In-111 chloride
Indium In-111 Chloride is a diagnostic radiopharmaceutical agent intended for radiolabeling OncoScint (satumomab pendetide) or ProstaScint (capromab pendetide) used for in vivo diagnostic imaging procedures and for radiolabeling Zevalin (ibritumomab tiuxetan) in preparations used for radioimmunotherapy procedures. It is supplied as a sterile, pyrogen-free solution of Indium ("'In) Chloride in...
Approved
Matched Description: … It is supplied as a sterile, pyrogen-free solution of Indium ("'In) Chloride in O.04M HCI. …
Mavacamten
Mavacamten is a myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM). It received initial US FDA approval in 2022, and it is one of the first myosin inhibitors to be used in humans. Mavacamten was also approved...
Approved
Investigational
Matched Description: … Mavacamten is a myosin inhibitor indicated for the treatment of adults with symptomatic New York Heart ... It received initial US FDA approval in 2022, and it is one of the first myosin inhibitors to be used …
Nitrofural
Nitrofural or nitrofurazone is a topical anti-infective agent effective against gram-negative and gram-positive bacteria. It is used for superficial wounds, burns, ulcers, and skin infections. Nitrofural has also been administered orally in the treatment of trypanosomiasis.
Except for topical drug products formulated for dermatologic application, the FDA withdrew its approval...
Approved
Investigational
Vet approved
Withdrawn
Matched Description: … Nitrofural has also been administered orally in the treatment of trypanosomiasis. ... topical drug products formulated for dermatologic application, the FDA withdrew its approval for the use of …
Donislecel
Donislecel is the first allogeneic pancreatic islet cellular from deceased donor pancreatic cells used for the treatment of adult type 1 diabetes with unsuccessful control of glycated hemoglobin, despite intensive diabetes management and treatments.[L47166,L47196] The primary mechanism of action of donislecel is attributed to the secretion of insulin and other...
Approved
Matched Description: … [L47166,L47196] The primary mechanism of action of donislecel is attributed to the secretion of insulin ... first allogeneic pancreatic islet cellular from deceased donor pancreatic cells used for the treatment of ... adult type 1 diabetes with unsuccessful control of glycated hemoglobin, despite intensive diabetes management …
Tebentafusp
Tebentafusp is a gp100 peptide-HLA-directed CD3 T cell engager. It is a bispecific, fusion protein and first-in-class drug of immune-mobilizing monoclonal T cell receptors against cancer (ImmTACs), a recently developed cancer immunotherapy with a novel mechanism of action. ImmTACs bind to target cancer cells that express a specific antigen of...
Approved
Investigational
Matched Description: … of action. ... cell receptors against cancer (ImmTACs), a recently developed cancer immunotherapy with a novel mechanism ... Even after surgical ablation or removal of the ocular tumour, almost 50% of patients with uveal melanoma …
Chloroxine
Chloroxine is a synthetic antibacterial compound. Chloroxine is a compound used in some shampoos for the treatment of dandruff and seborrheic dermatitis of the scalp.
Approved
Matched Description: … of the scalp. ... Chloroxine is a compound used in some shampoos for the treatment of dandruff and seborrheic dermatitis …
Dinoprostone
Dinoprostone is a naturally occurring prostaglandin E2 (PGE2). It has important effects in labour. It also stimulates osteoblasts to release factors which stimualtes bone resorption by osteoclasts. As a prescription drug it is used as a vaginal suppository, to prepare the cervix for labour and to induce labour.
Approved
Trimethobenzamide
Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ). In dogs pretreated with trimethobenzamide HCl, the emetic response to apomorphine is inhibited, while little or no protection is afforded against emesis induced by intragastric...
Approved
Investigational
Phensuximide
Phensuximide is a member of the succinimide class with anticonvulsant properties. It suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in petit mal seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
Approved
Matched Description: … The frequency of attacks is reduced by depression of nerve transmission in the motor cortex. ... Phensuximide is a member of the succinimide class with anticonvulsant properties. ... suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of …
Ropinirole
Ropinirole, also known as ReQuip, is a non-ergoline dopamine agonist used in Parkinson's disease and restless legs syndrome [FDA label], . It is manufactured by GlaxoSmithKline Pharmaceuticals. Ropinirole was initially approved in 1997 by the FDA [FDA label] for the management of Parkinson's disease. In 2005, it was the first...
Approved
Investigational
Matched Description: … In 2008, the extended-release capsules of ropinirole were approved, allowing for less frequent dosing ... Ropinirole was initially approved in 1997 by the FDA [FDA label] for the management of Parkinson's disease ... In 2005, it was the first drug approved in the US for the management of primary moderate to severe restless …
Nadroparin
Nadroparin is a low molecular weight heparin (LMWH) which, when bound to antithrombin III (ATIII), accelerates the inactivation of factor II and factor Xa. Nadroparin halts the coagulation pathway by inhibiting the activation of thrombin (factor IIa) by factor Xa. The amplification of the fibrin clotting cascade is stopped once...
Approved
Investigational
Matched Description: … It is derived from porcine sources and has a mean molecular size of 5000 daltons. ... The amplification of the fibrin clotting cascade is stopped once factors Xa and IIa are inactivated. ... molecular weight heparin (LMWH) which, when bound to antithrombin III (ATIII), accelerates the inactivation of …
Acetarsol
Acetarsol, with the molecular formula N-acetyl-4-hydroxy-m-arsanilic acid, is a pentavalent arsenical compound with antiprotozoal and antihelmintic properties. It was first discovered in 1921 by Ernest Fourneau at the Pasteur Institute. It was developed by Neolab Inc, and approved by Health Canada as an antifungal on December 31, 1964. It has...
Approved
Withdrawn
Bexarotene
Bexarotene (Targretin) is an antineoplastic agent indicated by the FDA for Cutaneous T cell lymphoma. It has been used off-label for lung cancer, breast cancer, and Kaposi's sarcoma.
Approved
Investigational
Povidone K30
A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle for pharmaceuticals; also used as blood volume expander. See povidone for full details.
Approved
Experimental
Matched Description: … A polyvinyl polymer of variable molecular weight; used as suspending and dispersing agent and vehicle …
Tegaserod
Novartis' brand name Zelnorm (tegaserod) had originally received approval from the US FDA in 2002 for the treatment of irritable bowel syndrome with constipation (IBS-C).[L5918,F4229] It was, however, voluntarily withdrawn from widespread use in the US market in 2007 after concerns arose over the possibility that tegaserod could potentially cause...
Approved
Investigational
Withdrawn
Matched Description: … of action of acting on serotonin-4 (5-HT(4)) receptors in smooth muscle cells and in the gastrointestinal ... its first introduction in 2002 tegaserod remains the only therapy for IBS-C that possesses the unique mechanism ... have resulted in the limited reintroduction or 're-approval' of tegaserod for treatment of IBS-C specifically …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Matched Categories: … Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome …
Piracetam
Piracetam is a nootropic drug in the racetams group, with chemical name 2-oxo-1-pyrrolidine acetamide. It shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid and is a cyclic derivative of the neurotransmitter γ-aminobutyric acid (GABA). However its mechanism of action differ from that of endogenous GABA. Piracetam has neuroprotective and...
Approved
Investigational
Matched Description: … However its mechanism of action differ from that of endogenous GABA. ... shares the same 2-oxo-pyrrolidone base structure with pyroglutamic acid and is a cyclic derivative of …
Displaying drugs 51 - 75 of 622 in total